BTMD biote Corp. logo

BTMD biote Corp.

Healthcare
$1.99-3.86%ClosedMarket Cap: $87.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

2.59

PEG

0.00

P/B

-1.09

P/S

0.47

EV/EBITDA

5.34

DCF Value

$3.86

FCF Yield

32.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

68.5%

Operating Margin

17.0%

Net Margin

8.3%

ROE

-22.9%

ROA

17.5%

ROIC

37.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$44.9M$2.3M$
Q4 null$46.4M$2.0M$
FY null$192.2M$27.0M$
Q3 null$48.0M$8.2M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$3.25

Target (Median)

$3.25

Target Range

$2.50 - $4.00

0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Truist SecuritiesBuy
2026-04-16
B. Riley SecuritiesNeutral
2026-03-12
TD CowenBuy
2026-03-12
B. Riley SecuritiesNeutral
2025-08-07

Trading Activity

Insider Trades

View All
HEYER ANDREW Rdirector
SellThu May 14
HEYER ANDREW Rdirector
SellThu May 14
MORRIS DEBRA Ldirector
SellWed May 13
MORRIS DEBRA Ldirector
SellWed May 13
MORRIS DEBRA Ldirector
SellWed May 13

Company Info

Sector

Healthcare

Industry

Medical - Care Facilities

Country

US

Exchange

Beta

1.71

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Peers